These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans. Wouters CW; Wever KE; Bronckers I; Hopman MT; Smits P; Thijssen DH; Rongen GA J Cardiovasc Pharmacol; 2012 Jan; 59(1):22-8. PubMed ID: 21885990 [TBL] [Abstract][Full Text] [Related]
11. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study. Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H; Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis. La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729 [TBL] [Abstract][Full Text] [Related]
13. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension. Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects. Tannous M; Cheung R; Vignini A; Mutus B Thromb Haemost; 1999 Nov; 82(5):1390-4. PubMed ID: 10595624 [TBL] [Abstract][Full Text] [Related]
15. Effects of oxytocin in normal man during low and high sodium diets. Rasmussen MS; Simonsen JA; Sandgaard NC; Høilund-Carlsen PF; Bie P Acta Physiol Scand; 2004 Jun; 181(2):247-57. PubMed ID: 15180798 [TBL] [Abstract][Full Text] [Related]
17. The effect of oral contraceptives on the nitric oxide system and renal function. Cherney DZ; Scholey JW; Cattran DC; Kang AK; Zimpelmann J; Kennedy C; Lai V; Burns KD; Miller JA Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1539-44. PubMed ID: 17715260 [TBL] [Abstract][Full Text] [Related]
18. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation? Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes. Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]